Doesn't look good for K2, money continues to flow consistently out the door. When the business started twenty years ago global equities out of Australia was far less competitive. 2/20 fee structure has all but disappeared. With significantly higher fees and sub par returns not going to get the ratings back. Cost base too high, Campbell Neal needs to swallow pride and cut his base, business with under 400 mil and disappearing funds can't take the overheads.
- Forums
- ASX - By Stock
- KAM
- Ann: Half Yearly Report and Accounts
Ann: Half Yearly Report and Accounts, page-2
Featured News
Add KAM (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.05M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 6.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.9¢ | 24020 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 30000 | 0.071 |
2 | 163100 | 0.070 |
1 | 23000 | 0.066 |
1 | 60000 | 0.063 |
1 | 100000 | 0.061 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 50000 | 1 |
0.081 | 22275 | 2 |
0.082 | 11500 | 1 |
0.085 | 45971 | 1 |
0.089 | 2700 | 1 |
Last trade - 11.00am 25/11/2024 (20 minute delay) ? |
Featured News
KAM (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online